Niranjan Sardesai, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), bought 10,000 shares at $0.45 ($5K) on 2012-05-16, disclosed to the SEC on 2012-05-17.
Open-market purchase of $4k INO by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| INO | BUY | 2014-08-12 | $22K | — | Filing → |
| INO | BUY | 2013-03-22 | $13K | — | Filing → |